Showing all published months. Partner preview tables include up to 5 countries.
USD value by month, all available partner countries combined
Free partner preview shows up to 5 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| India | $63.9M | 15.8% |
| Spain | $39.7M | 9.8% |
| Vietnam | $25.4M | 6.3% |
| Romania | $23.4M | 5.8% |
| South Korea | $22M | 5.4% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| Germany | $2.8M | 19.9% |
| South Korea | $1.6M | 11.7% |
| Italy | $1.6M | 11.6% |
| Romania | $1.6M | 11.6% |
| India | $1.3M | 9.6% |
| Year | Export value |
|---|---|
| 2021 | $59.6M |
| 2022 | $65M |
| 2023 | $63.3M |
| 2024 | $71.6M |
| 2025 | $65.2M |
| 2026 | $79.4M |
China customs reports HS 300310 at the 8-digit level. 4 subheadings are published under it, and export values for each are available on request.
Bulk pharmaceutical preparations formulated with ampicillin, supplied in large containers for subsequent processing rather than individual retail or measured-dose packaging.
Bulk pharmaceutical preparations formulated with amoxycillin, supplied in large containers for subsequent processing rather than individual retail or measured-dose packaging.
Bulk pharmaceutical preparations formulated with other penicillin variants or their derivatives, packaged for further formulation rather than direct retail or measured-dose use.
Bulk pharmaceutical preparations formulated with streptomycins or their derivatives, packaged for further formulation rather than direct retail or measured-dose use.
Public data shows up to 5 partner countries. Request all available countries, years, quantity fields, or HS8 detail in CSV.
HS 300310 is also written 3003.10. Values are in USD; the public series does not report tonnes or kg. Product scope: Bulk pharmaceutical preparations containing penicillin or its derivatives, packaged in large containers for further formulation rather than individual measured doses for direct patient use. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Penicillins medicine (HS 300310) Export Data." https://chinadata.live/china-trade/hs/300310/
HS 300310 is also written 3003.10. Values are in USD; the public series does not report tonnes or kg. Product scope: Bulk pharmaceutical preparations containing penicillin or its derivatives, packaged in large containers for further formulation rather than individual measured doses for direct patient use. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Penicillins medicine (HS 300310) Export Data." https://chinadata.live/china-trade/hs/300310/
China exported $98.3M of penicillins medicine in the twelve months to August 2026, averaging $8.2M per month, based on official China customs statistics (HS 300310).
Bulk pharmaceutical preparations containing penicillin or its derivatives, packaged in large containers for further formulation rather than individual measured doses for direct patient use.
India, Spain and Vietnam together account for 32% of the published total, out of 34 trading partners on record.
Annual exports grew by 9% between 2021 and 2025, from $59.6M to $65.2M.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available on request.